Tirzepatide

$75.00 – $300.00

Tirzepatide is a dual-action research peptide that targets both GLP-1 and GIP receptors, studied for its potential to regulate blood sugar levels and support weight management.

Note: Tirzepatide is intended for research and laboratory purposes only and is not for human use or consumption.

SKU: N/A Category: Peptides

Tirzepatide is a groundbreaking dual-agonist research peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, key hormones involved in metabolic regulation. This dual-action mechanism offers a synergistic approach to improving glucose control, enhancing insulin sensitivity, and reducing appetite, making Tirzepatide a promising subject in research related to type 2 diabetes and obesity management.

Studies have shown that Tirzepatide’s innovative approach may lead to improved glycemic control, reduced body weight, and better overall metabolic health. Its multifaceted benefits have sparked significant interest in understanding its potential applications in metabolic and endocrine research.

Note: Tirzepatide is for research purposes only and is not approved for human consumption or therapeutic use.